TB Diagnostic Market Thumbnail Image

2023

TB Diagnostic Market

TB Diagnostic Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by End-User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: Prathmesh Bhasme | Roshan Deshmukh
Publish Date:

Get Sample to Email

TB Diagnostic Market Research, 2032

The global tb diagnostic market was valued at $2.1 billion in 2022, and is projected to reach $3.1 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032. TB is an bacterial infectious disease caused by Mycobacterium tuberculosis (Mtb). It is majorly affects lungs and the infection can spread to other organs. The TB can be diagnosed with the various test such as culture-based tests, sputum smear test, and molecular diagnosis

 

TB Diagnostic Market

Market Dynamics

The increase in prevalence of TB and the rise in the number of patients hospitalized for TB therapy boost the growth of the TB diagnostics industry. Furthermore, the rise in the prevalence of infectious diseases and the increase in number of TB patients contributes to the TB Diagnostic Market Growth. For instance, according to in 2021, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide.

Moreover, the improved healthcare infrastructure and growing demand for unmet healthcare needs is expected to create remunerative opportunities for the expansion of the TB Diagnostic Industry. In addition, key players have adopted various strategies such as product launches, acquisitions, agreements, partnerships, and collaborations to strengthen their foothold in the TB Diagnostic Industry. For instance, in March 2021, bioMérieux , a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection.  

The demand for TB diagnostics is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuels the growth of the TB Diagnostic Market Size. Factors such as a rise in hospital admissions, an increase in the number of surgeries, and a surge in healthcare expenditures drive the growth of the TB Diagnostic Market Size. In addition, an increase in incidences of accidents and emergency health conditions is expected to fuel the growth of the industry.

However, the high cost associated with TB diagnosis may hampers market growth.

Segmental Overview

The TB diagnostic market is segmented into type, end user, and region. On the basis of type, the market is classified into culture-based diagnosis, sputum smear test, rapid molecular diagnosis and others. On the basis of end user, it is categorized into hospitals, diagnostic labs, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

By Type

On the basis of the type, the market is classified into culture-based diagnosis, sputum smear test, rapid molecular diagnosis and others. The rapid molecular diagnosis segment dominated the global TB Diagnostic Market Share in 2022 and is expected to remain dominant throughout the forecast period owing to an increase in the prevalence of TB and a rise in the demand for advanced diagnostic tools. Moreover, surge in geriatric population is anticipated to boost the demand for TB diagnostics. This is attributed to the fact that aged individuals are highly susceptible to infectious diseases.

TB Diagnostic Market by Type

By End User

On the basis of end user, the market is divided into hospital, diagnostic labs, and others. The diagnostic labs segment dominated the global TB Diagnostic Market Share in 2022 and is anticipated to continue this trend during the TB Diagnostic Market Forecast period. This is attributed to an increase in the adoption of TB diagnostics in hospitals. In addition, an increase in the number of diagnostic labs, visits drives the growth of the market as the TB diagnostic. Moreover, improvements in the healthcare infrastructure drives the growth of market.

TB Diagnostic Market by End-User

By Region

On the basis of region, the TB diagnostic market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2022, North America was the dominant region and is expected to continue this trend throughout the forecast period owing to high prevalence of TB, the strong presence of key players, and the surge in the number of critically ill patients in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high population countries such as India and China, which, in turn, increases the prevalence of TB and the growing number of strategies and trends adopted by the market players that include product development, product approval, partnership, collaboration, and agreement.

TB Diagnostic Market by Region

COMPETITION ANALYSIS

Competitive analysis and profiles of the major players in the TB diagnostic market such as include Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Molbio Diagnostics, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmon La-Roche, Hologic Inc., Qiagen Inc and ThermoFisher Scientific. are provided in this report. These players have adopted product launch and product development as key developmental strategies to improve the product portfolio of the TB diagnostic.  

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tb diagnostic market analysis from 2022 to 2032 to identify the prevailing TB Diagnostic Market Opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the tb diagnostic market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global tb diagnostic market trends, key players, market segments, application areas, and market growth strategies.

TB Diagnostic Market Report Highlights

Aspects Details
icon_1
Market Size By 2032

USD 3.1 billion

icon_2
Growth Rate

CAGR of 4.1%

icon_3
Forecast period

2022 - 2032

icon_4
Report Pages

250

icon_5
By Type
  • Culture based diagnosis
  • Sputum test
  • Rapid Molecular Diagnosis
  • Others
icon_6
By End-User
  • Hospitals
  • Diagnostic labs
  • Others
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
icon_8
Key Market Players

Qiagen NV., Thermo Fisher Scientific Inc., Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories, Inc. , Hologic Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Molbio Diagnostics Pvt. Ltd., Becton Dickinson & Company

Analyst Review

This section provides opinions of the top-level CXOs in the TB diagnostic market. The tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis that primarily affects the lungs but also affect other parts of the body. TB is diagnosed with various tests such as TB skin test (TST) and TB blood tests. The increase in the prevalence of TB infection, advancements in TB diagnosis, and a rise in the geriatric population drive the market growth.

In addition, the strategies such as product approvals, product launch, acquisition, and merger, adopted by key players, contribute to the growth of the market. For instance, in March 2021, bioMérieux, a world leader in the field of in vitro diagnostics, announced the CE marking of its innovative and fully-automated test VIDAS TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection.

Author Name(s) : Prathmesh Bhasme | Roshan Deshmukh
Frequently Asked Questions?

The total market value of the Tb diagnostic Market is $2,066.7 million in 2022..

The forecast period in the report is from 2023 to 2032

North America is the largest regional market for TB Diagnostic

There are 10 Tb diagnostic manufacturing companies are profiled in the report.

The base year for the report is 2022.

Yes, Tb diagnostic companies are profiled in the report

The top companies that hold the market share in Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Molbio Diagnostics, and Bio-Rad Laboratories

Yes, the competitive landscape included in the Tb diagnostic market report

Loading Table Of Content...

Loading Research Methodology...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

TB Diagnostic Market

Global Opportunity Analysis and Industry Forecast, 2023-2032